MarketInOut Stock Screener Log In | Sign Up

Tetratherix Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 16:10
Tetratherix Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization272.46 mln
Float14.46 mln
Earnings Date03/01/2027

Piotroski F-Score

4 / 9
Borderline

Relative Strength

13 / 100
Significantly lagging

Debt / Equity

0.34
Low leverage

Pre-Tax Margin

-1,015%
Severely loss-making

ROE

-33.15
Deeply negative

Altman Z-Score

8.59
Exceptional

Business Description

Founded in 2015 and headquartered in Alexandria, Australia, Tetratherix Limited develops and sells medical products designed to help the body repair bone and tissue. The company operates both domestically and abroad, bringing its proprietary Tetramatrix technology to market across applications in bone growth, tissue separation, and wound healing.

Key Fundamentals

EPS-0.18
ROE-33.15
RPS0.08
ROIC-90.54
ROA-22.72
EBITDA, mln-7.85
EV / EBITDA-37.03
EV / EBIT-33.14
Revenue, mln0.92
EV / Revenue317

Quote Details

Last 5.35
Change -0.15 (-2.73%)
Open 5.70
Volume 7,155
Turnover 38,279
Average Volume 15,461

Financial Ratios

Pre-Tax Profit Margin-1,015
Current Ratio4.50
Price / Book10.21
Price / Tangible Book9.87
Debt / Equity0.34
Price / Sales371

Financial Strength

Altman Z-Score8.59
Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.08% 25 / 100   
1 Month -15.08% 24 / 100   
2 Months -24.33% 18 / 100   
6 Months 11.46% 84 / 100   
1 Year 15.05% 81 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog